nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenobarbital—ABCC1—Vemurafenib—skin cancer	0.0945	0.11	CbGbCtD
Phenobarbital—ABCC3—Fluorouracil—skin cancer	0.0692	0.0805	CbGbCtD
Phenobarbital—ABCC1—Dactinomycin—skin cancer	0.0628	0.0731	CbGbCtD
Phenobarbital—CYP1A2—Imiquimod—skin cancer	0.0476	0.0554	CbGbCtD
Phenobarbital—CYP1B1—Docetaxel—skin cancer	0.0456	0.0531	CbGbCtD
Phenobarbital—CYP1A1—Dacarbazine—skin cancer	0.0447	0.0521	CbGbCtD
Phenobarbital—CYP2C8—Vismodegib—skin cancer	0.0426	0.0496	CbGbCtD
Phenobarbital—CYP2C19—Vismodegib—skin cancer	0.0358	0.0416	CbGbCtD
Phenobarbital—CYP2E1—Dacarbazine—skin cancer	0.0346	0.0402	CbGbCtD
Phenobarbital—ABCC1—Docetaxel—skin cancer	0.0324	0.0377	CbGbCtD
Phenobarbital—CYP2A6—Fluorouracil—skin cancer	0.0307	0.0357	CbGbCtD
Phenobarbital—CYP2C9—Vismodegib—skin cancer	0.0297	0.0346	CbGbCtD
Phenobarbital—ABCB1—Vismodegib—skin cancer	0.0288	0.0336	CbGbCtD
Phenobarbital—CYP1A2—Vemurafenib—skin cancer	0.0261	0.0303	CbGbCtD
Phenobarbital—CYP3A4—Imiquimod—skin cancer	0.0249	0.029	CbGbCtD
Phenobarbital—CYP3A4—Temozolomide—skin cancer	0.0249	0.029	CbGbCtD
Phenobarbital—ABCC2—Docetaxel—skin cancer	0.024	0.0279	CbGbCtD
Phenobarbital—CYP1A2—Dacarbazine—skin cancer	0.02	0.0233	CbGbCtD
Phenobarbital—CYP3A4—Vismodegib—skin cancer	0.0173	0.0201	CbGbCtD
Phenobarbital—CYP3A7—Docetaxel—skin cancer	0.016	0.0187	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.016	0.0187	CbGbCtD
Phenobarbital—ABCB1—Dactinomycin—skin cancer	0.0152	0.0176	CbGbCtD
Phenobarbital—CYP2C8—Fluorouracil—skin cancer	0.0151	0.0176	CbGbCtD
Phenobarbital—CYP3A4—Vemurafenib—skin cancer	0.0137	0.0159	CbGbCtD
Phenobarbital—CYP3A5—Docetaxel—skin cancer	0.012	0.014	CbGbCtD
Phenobarbital—CYP1A2—Fluorouracil—skin cancer	0.0117	0.0136	CbGbCtD
Phenobarbital—CYP2C9—Fluorouracil—skin cancer	0.0106	0.0123	CbGbCtD
Phenobarbital—ABCB1—Docetaxel—skin cancer	0.00782	0.00911	CbGbCtD
Phenobarbital—CYP3A4—Docetaxel—skin cancer	0.00469	0.00546	CbGbCtD
Phenobarbital—GRIK2—nerve—skin cancer	0.00255	0.0587	CbGeAlD
Phenobarbital—CHRNA7—skin epidermis—skin cancer	0.00244	0.0561	CbGeAlD
Phenobarbital—Congenital anomaly—Fluorouracil—skin cancer	0.00237	0.0247	CcSEcCtD
Phenobarbital—Developmental delay—Fluorouracil—skin cancer	0.00237	0.0247	CcSEcCtD
Phenobarbital—CHRNA4—nerve—skin cancer	0.00205	0.0471	CbGeAlD
Phenobarbital—SLCO2A1—nipple—skin cancer	0.00144	0.0331	CbGeAlD
Phenobarbital—SLCO2A1—neck—skin cancer	0.00142	0.0327	CbGeAlD
Phenobarbital—Ethotoin—SCN10A—skin cancer	0.00141	1	CrCbGaD
Phenobarbital—CYP4B1—mammalian vulva—skin cancer	0.0014	0.0323	CbGeAlD
Phenobarbital—Necrosis—Dactinomycin—skin cancer	0.00138	0.0144	CcSEcCtD
Phenobarbital—Extravasation—Bleomycin—skin cancer	0.00133	0.0138	CcSEcCtD
Phenobarbital—CYP1B1—hair follicle—skin cancer	0.00128	0.0293	CbGeAlD
Phenobarbital—CYP1A1—skin epidermis—skin cancer	0.00126	0.029	CbGeAlD
Phenobarbital—Nystagmus—Fluorouracil—skin cancer	0.00126	0.0131	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Imiquimod—skin cancer	0.00125	0.0131	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Vemurafenib—skin cancer	0.00125	0.013	CcSEcCtD
Phenobarbital—Blister—Fluorouracil—skin cancer	0.00125	0.013	CcSEcCtD
Phenobarbital—Extravasation—Dactinomycin—skin cancer	0.00124	0.0129	CcSEcCtD
Phenobarbital—Lethargy—Imiquimod—skin cancer	0.00121	0.0126	CcSEcCtD
Phenobarbital—CYP4B1—female reproductive system—skin cancer	0.0012	0.0276	CbGeAlD
Phenobarbital—Hypocalcaemia—Dactinomycin—skin cancer	0.00118	0.0123	CcSEcCtD
Phenobarbital—CHRNA7—neck—skin cancer	0.00117	0.0268	CbGeAlD
Phenobarbital—Liver injury—Temozolomide—skin cancer	0.00116	0.0121	CcSEcCtD
Phenobarbital—Myalgia—Vismodegib—skin cancer	0.00115	0.012	CcSEcCtD
Phenobarbital—Arthralgia—Vismodegib—skin cancer	0.00115	0.012	CcSEcCtD
Phenobarbital—ABCC1—hair follicle—skin cancer	0.00115	0.0264	CbGeAlD
Phenobarbital—Necrosis—Fluorouracil—skin cancer	0.00115	0.012	CcSEcCtD
Phenobarbital—Irritability—Imiquimod—skin cancer	0.00113	0.0118	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00106	0.0111	CcSEcCtD
Phenobarbital—CYP2C18—mammalian vulva—skin cancer	0.00104	0.024	CbGeAlD
Phenobarbital—Extravasation—Fluorouracil—skin cancer	0.00103	0.0108	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00101	0.0105	CcSEcCtD
Phenobarbital—CYP4B1—head—skin cancer	0.001	0.0231	CbGeAlD
Phenobarbital—Respiratory failure—Temozolomide—skin cancer	0.000994	0.0104	CcSEcCtD
Phenobarbital—SLCO2A1—epithelium—skin cancer	0.000969	0.0223	CbGeAlD
Phenobarbital—Constipation—Vismodegib—skin cancer	0.000943	0.00985	CcSEcCtD
Phenobarbital—Pain—Vismodegib—skin cancer	0.000943	0.00985	CcSEcCtD
Phenobarbital—Depressed level of consciousness—Temozolomide—skin cancer	0.000943	0.00984	CcSEcCtD
Phenobarbital—SLCO2A1—skin of body—skin cancer	0.000921	0.0212	CbGeAlD
Phenobarbital—Erythema multiforme—Vemurafenib—skin cancer	0.000907	0.00947	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.000904	0.00943	CcSEcCtD
Phenobarbital—Mental disability—Temozolomide—skin cancer	0.000847	0.00884	CcSEcCtD
Phenobarbital—SLCO2A1—mammalian vulva—skin cancer	0.00084	0.0193	CbGeAlD
Phenobarbital—Erythema—Vemurafenib—skin cancer	0.000835	0.00872	CcSEcCtD
Phenobarbital—Necrosis—Docetaxel—skin cancer	0.000827	0.00863	CcSEcCtD
Phenobarbital—Coma—Fluorouracil—skin cancer	0.000822	0.00858	CcSEcCtD
Phenobarbital—Lethargy—Dactinomycin—skin cancer	0.0008	0.00835	CcSEcCtD
Phenobarbital—ABCC1—nipple—skin cancer	0.000778	0.0179	CbGeAlD
Phenobarbital—Erythema multiforme—Imiquimod—skin cancer	0.000774	0.00807	CcSEcCtD
Phenobarbital—CHRNA7—skin of body—skin cancer	0.000756	0.0174	CbGeAlD
Phenobarbital—Dermatitis exfoliative—Temozolomide—skin cancer	0.000751	0.00784	CcSEcCtD
Phenobarbital—Extravasation—Docetaxel—skin cancer	0.000744	0.00777	CcSEcCtD
Phenobarbital—CHRFAM7A—female reproductive system—skin cancer	0.000731	0.0168	CbGeAlD
Phenobarbital—SLCO2A1—female reproductive system—skin cancer	0.00072	0.0165	CbGeAlD
Phenobarbital—Erythema—Imiquimod—skin cancer	0.000712	0.00743	CcSEcCtD
Phenobarbital—Myalgia—Vemurafenib—skin cancer	0.000711	0.00742	CcSEcCtD
Phenobarbital—Arthralgia—Vemurafenib—skin cancer	0.000711	0.00742	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.000706	0.00737	CcSEcCtD
Phenobarbital—CYP4B1—lymph node—skin cancer	0.000704	0.0162	CbGeAlD
Phenobarbital—Vomiting—Vismodegib—skin cancer	0.000701	0.00732	CcSEcCtD
Phenobarbital—Affect lability—Temozolomide—skin cancer	0.000698	0.00728	CcSEcCtD
Phenobarbital—Rash—Vismodegib—skin cancer	0.000696	0.00726	CcSEcCtD
Phenobarbital—Dermatitis—Vismodegib—skin cancer	0.000695	0.00725	CcSEcCtD
Phenobarbital—Dermatitis bullous—Fluorouracil—skin cancer	0.000683	0.00713	CcSEcCtD
Phenobarbital—Mood swings—Temozolomide—skin cancer	0.000671	0.00701	CcSEcCtD
Phenobarbital—GRIA2—head—skin cancer	0.00067	0.0154	CbGeAlD
Phenobarbital—Ataxia—Temozolomide—skin cancer	0.000666	0.00696	CcSEcCtD
Phenobarbital—Lethargy—Fluorouracil—skin cancer	0.000666	0.00696	CcSEcCtD
Phenobarbital—Respiratory failure—Docetaxel—skin cancer	0.000661	0.0069	CcSEcCtD
Phenobarbital—Nausea—Vismodegib—skin cancer	0.000655	0.00684	CcSEcCtD
Phenobarbital—Agitation—Imiquimod—skin cancer	0.000654	0.00683	CcSEcCtD
Phenobarbital—Angioedema—Imiquimod—skin cancer	0.000651	0.00679	CcSEcCtD
Phenobarbital—Hepatocellular injury—Docetaxel—skin cancer	0.000649	0.00678	CcSEcCtD
Phenobarbital—Injection site reaction—Docetaxel—skin cancer	0.000645	0.00674	CcSEcCtD
Phenobarbital—Syncope—Imiquimod—skin cancer	0.000639	0.00667	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.000638	0.00666	CcSEcCtD
Phenobarbital—Hypotension—Vemurafenib—skin cancer	0.000637	0.00665	CcSEcCtD
Phenobarbital—Loss of consciousness—Imiquimod—skin cancer	0.000626	0.00653	CcSEcCtD
Phenobarbital—Irritability—Fluorouracil—skin cancer	0.000623	0.00651	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000621	0.00648	CcSEcCtD
Phenobarbital—CYP1A2—nipple—skin cancer	0.00062	0.0142	CbGeAlD
Phenobarbital—Ataxia—Fluorouracil—skin cancer	0.000614	0.00641	CcSEcCtD
Phenobarbital—CYP1B1—connective tissue—skin cancer	0.000613	0.0141	CbGeAlD
Phenobarbital—CYP1A1—nipple—skin cancer	0.000611	0.014	CbGeAlD
Phenobarbital—CHRFAM7A—head—skin cancer	0.000611	0.014	CbGeAlD
Phenobarbital—Arthralgia—Imiquimod—skin cancer	0.000606	0.00633	CcSEcCtD
Phenobarbital—Myalgia—Imiquimod—skin cancer	0.000606	0.00633	CcSEcCtD
Phenobarbital—GRIK2—head—skin cancer	0.000606	0.0139	CbGeAlD
Phenobarbital—Anxiety—Imiquimod—skin cancer	0.000604	0.00631	CcSEcCtD
Phenobarbital—SLCO2A1—head—skin cancer	0.000601	0.0138	CbGeAlD
Phenobarbital—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.000599	0.00625	CcSEcCtD
Phenobarbital—CHRNA7—female reproductive system—skin cancer	0.00059	0.0136	CbGeAlD
Phenobarbital—Constipation—Vemurafenib—skin cancer	0.000583	0.00608	CcSEcCtD
Phenobarbital—Shock—Imiquimod—skin cancer	0.000572	0.00597	CcSEcCtD
Phenobarbital—CYP1B1—skin of body—skin cancer	0.000554	0.0127	CbGeAlD
Phenobarbital—ABCC3—female reproductive system—skin cancer	0.000553	0.0127	CbGeAlD
Phenobarbital—Hepatitis—Dactinomycin—skin cancer	0.000542	0.00566	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000541	0.00565	CcSEcCtD
Phenobarbital—Body temperature increased—Vemurafenib—skin cancer	0.000539	0.00562	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00053	0.00553	CcSEcCtD
Phenobarbital—Somnolence—Imiquimod—skin cancer	0.000517	0.00539	CcSEcCtD
Phenobarbital—Erythema multiforme—Dactinomycin—skin cancer	0.000513	0.00535	CcSEcCtD
Phenobarbital—Erythema—Bleomycin—skin cancer	0.000506	0.00528	CcSEcCtD
Phenobarbital—Hypersensitivity—Vemurafenib—skin cancer	0.000502	0.00524	CcSEcCtD
Phenobarbital—Pain—Imiquimod—skin cancer	0.000497	0.00519	CcSEcCtD
Phenobarbital—CHRNA7—head—skin cancer	0.000493	0.0113	CbGeAlD
Phenobarbital—Dermatitis bullous—Docetaxel—skin cancer	0.000493	0.00515	CcSEcCtD
Phenobarbital—Hepatitis—Temozolomide—skin cancer	0.00049	0.00512	CcSEcCtD
Phenobarbital—Hallucination—Temozolomide—skin cancer	0.000488	0.00509	CcSEcCtD
Phenobarbital—CHRNA4—head—skin cancer	0.000487	0.0112	CbGeAlD
Phenobarbital—Lethargy—Docetaxel—skin cancer	0.000481	0.00502	CcSEcCtD
Phenobarbital—Feeling abnormal—Imiquimod—skin cancer	0.000479	0.005	CcSEcCtD
Phenobarbital—Erythema—Dactinomycin—skin cancer	0.000472	0.00493	CcSEcCtD
Phenobarbital—Erythema multiforme—Temozolomide—skin cancer	0.000464	0.00484	CcSEcCtD
Phenobarbital—Urticaria—Imiquimod—skin cancer	0.000462	0.00482	CcSEcCtD
Phenobarbital—ABCC3—head—skin cancer	0.000462	0.0106	CbGeAlD
Phenobarbital—Body temperature increased—Imiquimod—skin cancer	0.000459	0.0048	CcSEcCtD
Phenobarbital—ABCC1—mammalian vulva—skin cancer	0.000454	0.0104	CbGeAlD
Phenobarbital—Dizziness—Vemurafenib—skin cancer	0.000451	0.0047	CcSEcCtD
Phenobarbital—CYP1B1—lymphoid tissue—skin cancer	0.000448	0.0103	CbGeAlD
Phenobarbital—Ataxia—Docetaxel—skin cancer	0.000443	0.00463	CcSEcCtD
Phenobarbital—ABCC2—female reproductive system—skin cancer	0.000442	0.0101	CbGeAlD
Phenobarbital—ABCB1—blood vessel—skin cancer	0.000439	0.0101	CbGeAlD
Phenobarbital—Vomiting—Vemurafenib—skin cancer	0.000433	0.00452	CcSEcCtD
Phenobarbital—CYP1B1—female reproductive system—skin cancer	0.000432	0.00994	CbGeAlD
Phenobarbital—Myalgia—Bleomycin—skin cancer	0.000431	0.0045	CcSEcCtD
Phenobarbital—Rash—Vemurafenib—skin cancer	0.00043	0.00449	CcSEcCtD
Phenobarbital—Dermatitis—Vemurafenib—skin cancer	0.000429	0.00448	CcSEcCtD
Phenobarbital—Hypersensitivity—Imiquimod—skin cancer	0.000428	0.00447	CcSEcCtD
Phenobarbital—Headache—Vemurafenib—skin cancer	0.000427	0.00446	CcSEcCtD
Phenobarbital—Erythema—Temozolomide—skin cancer	0.000427	0.00446	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000424	0.00443	CcSEcCtD
Phenobarbital—SLCO2A1—lymph node—skin cancer	0.000421	0.00967	CbGeAlD
Phenobarbital—GABRA1—head—skin cancer	0.000421	0.00967	CbGeAlD
Phenobarbital—Confusional state—Bleomycin—skin cancer	0.000416	0.00435	CcSEcCtD
Phenobarbital—CYP1A1—epithelium—skin cancer	0.000412	0.00946	CbGeAlD
Phenobarbital—Nausea—Vemurafenib—skin cancer	0.000405	0.00423	CcSEcCtD
Phenobarbital—Myalgia—Dactinomycin—skin cancer	0.000402	0.00419	CcSEcCtD
Phenobarbital—Erythema—Fluorouracil—skin cancer	0.000393	0.0041	CcSEcCtD
Phenobarbital—Agitation—Temozolomide—skin cancer	0.000392	0.00409	CcSEcCtD
Phenobarbital—CYP1A1—skin of body—skin cancer	0.000391	0.00899	CbGeAlD
Phenobarbital—Angioedema—Temozolomide—skin cancer	0.00039	0.00407	CcSEcCtD
Phenobarbital—Hypotension—Bleomycin—skin cancer	0.000386	0.00403	CcSEcCtD
Phenobarbital—Dizziness—Imiquimod—skin cancer	0.000384	0.00401	CcSEcCtD
Phenobarbital—Vertigo—Temozolomide—skin cancer	0.000383	0.004	CcSEcCtD
Phenobarbital—CYP2B6—skin of body—skin cancer	0.00038	0.00874	CbGeAlD
Phenobarbital—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000376	0.00393	CcSEcCtD
Phenobarbital—Vomiting—Imiquimod—skin cancer	0.00037	0.00386	CcSEcCtD
Phenobarbital—Rash—Imiquimod—skin cancer	0.000366	0.00383	CcSEcCtD
Phenobarbital—Dermatitis—Imiquimod—skin cancer	0.000366	0.00382	CcSEcCtD
Phenobarbital—Headache—Imiquimod—skin cancer	0.000364	0.0038	CcSEcCtD
Phenobarbital—Myalgia—Temozolomide—skin cancer	0.000363	0.00379	CcSEcCtD
Phenobarbital—Arthralgia—Temozolomide—skin cancer	0.000363	0.00379	CcSEcCtD
Phenobarbital—Anxiety—Temozolomide—skin cancer	0.000362	0.00378	CcSEcCtD
Phenobarbital—CYP1B1—head—skin cancer	0.000361	0.0083	CbGeAlD
Phenobarbital—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00036	0.00376	CcSEcCtD
Phenobarbital—Renal failure—Docetaxel—skin cancer	0.000357	0.00373	CcSEcCtD
Phenobarbital—CYP1A1—mammalian vulva—skin cancer	0.000357	0.0082	CbGeAlD
Phenobarbital—Pain—Bleomycin—skin cancer	0.000353	0.00369	CcSEcCtD
Phenobarbital—Confusional state—Temozolomide—skin cancer	0.000351	0.00367	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000351	0.00366	CcSEcCtD
Phenobarbital—Nausea—Imiquimod—skin cancer	0.000345	0.0036	CcSEcCtD
Phenobarbital—Feeling abnormal—Bleomycin—skin cancer	0.00034	0.00355	CcSEcCtD
Phenobarbital—Myalgia—Fluorouracil—skin cancer	0.000335	0.00349	CcSEcCtD
Phenobarbital—CYP2C8—female reproductive system—skin cancer	0.000331	0.00761	CbGeAlD
Phenobarbital—Pain—Dactinomycin—skin cancer	0.000329	0.00344	CcSEcCtD
Phenobarbital—Urticaria—Bleomycin—skin cancer	0.000328	0.00342	CcSEcCtD
Phenobarbital—Body temperature increased—Bleomycin—skin cancer	0.000326	0.00341	CcSEcCtD
Phenobarbital—Hepatitis—Docetaxel—skin cancer	0.000326	0.0034	CcSEcCtD
Phenobarbital—Confusional state—Fluorouracil—skin cancer	0.000324	0.00338	CcSEcCtD
Phenobarbital—ABCC3—lymph node—skin cancer	0.000323	0.00743	CbGeAlD
Phenobarbital—Feeling abnormal—Dactinomycin—skin cancer	0.000317	0.00331	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000317	0.00331	CcSEcCtD
Phenobarbital—Somnolence—Temozolomide—skin cancer	0.00031	0.00323	CcSEcCtD
Phenobarbital—Erythema multiforme—Docetaxel—skin cancer	0.000308	0.00322	CcSEcCtD
Phenobarbital—CYP2B6—lymphoid tissue—skin cancer	0.000308	0.00708	CbGeAlD
Phenobarbital—CYP1A1—female reproductive system—skin cancer	0.000306	0.00703	CbGeAlD
Phenobarbital—Body temperature increased—Dactinomycin—skin cancer	0.000304	0.00318	CcSEcCtD
Phenobarbital—Hypersensitivity—Bleomycin—skin cancer	0.000304	0.00318	CcSEcCtD
Phenobarbital—Hypotension—Fluorouracil—skin cancer	0.0003	0.00313	CcSEcCtD
Phenobarbital—Pain—Temozolomide—skin cancer	0.000298	0.00311	CcSEcCtD
Phenobarbital—Constipation—Temozolomide—skin cancer	0.000298	0.00311	CcSEcCtD
Phenobarbital—CYP2B6—female reproductive system—skin cancer	0.000297	0.00683	CbGeAlD
Phenobarbital—CYP2C9—female reproductive system—skin cancer	0.000294	0.00676	CbGeAlD
Phenobarbital—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000292	0.00305	CcSEcCtD
Phenobarbital—CYP2E1—lymphoid tissue—skin cancer	0.000289	0.00664	CbGeAlD
Phenobarbital—Feeling abnormal—Temozolomide—skin cancer	0.000287	0.003	CcSEcCtD
Phenobarbital—Somnolence—Fluorouracil—skin cancer	0.000285	0.00298	CcSEcCtD
Phenobarbital—Erythema—Docetaxel—skin cancer	0.000284	0.00296	CcSEcCtD
Phenobarbital—Hypersensitivity—Dactinomycin—skin cancer	0.000284	0.00296	CcSEcCtD
Phenobarbital—CYP2E1—female reproductive system—skin cancer	0.000279	0.00641	CbGeAlD
Phenobarbital—Urticaria—Temozolomide—skin cancer	0.000277	0.00289	CcSEcCtD
Phenobarbital—Body temperature increased—Temozolomide—skin cancer	0.000275	0.00287	CcSEcCtD
Phenobarbital—Pain—Fluorouracil—skin cancer	0.000274	0.00286	CcSEcCtD
Phenobarbital—Feeling abnormal—Fluorouracil—skin cancer	0.000264	0.00276	CcSEcCtD
Phenobarbital—Vomiting—Bleomycin—skin cancer	0.000263	0.00274	CcSEcCtD
Phenobarbital—Rash—Bleomycin—skin cancer	0.00026	0.00272	CcSEcCtD
Phenobarbital—Dermatitis—Bleomycin—skin cancer	0.00026	0.00272	CcSEcCtD
Phenobarbital—ABCC2—lymph node—skin cancer	0.000258	0.00594	CbGeAlD
Phenobarbital—Hypersensitivity—Temozolomide—skin cancer	0.000257	0.00268	CcSEcCtD
Phenobarbital—CYP1A1—head—skin cancer	0.000255	0.00587	CbGeAlD
Phenobarbital—Urticaria—Fluorouracil—skin cancer	0.000255	0.00266	CcSEcCtD
Phenobarbital—Syncope—Docetaxel—skin cancer	0.000255	0.00266	CcSEcCtD
Phenobarbital—Body temperature increased—Fluorouracil—skin cancer	0.000254	0.00265	CcSEcCtD
Phenobarbital—CYP1B1—lymph node—skin cancer	0.000253	0.00581	CbGeAlD
Phenobarbital—Loss of consciousness—Docetaxel—skin cancer	0.000249	0.0026	CcSEcCtD
Phenobarbital—CYP2B6—head—skin cancer	0.000248	0.0057	CbGeAlD
Phenobarbital—Nausea—Bleomycin—skin cancer	0.000245	0.00256	CcSEcCtD
Phenobarbital—Vomiting—Dactinomycin—skin cancer	0.000245	0.00256	CcSEcCtD
Phenobarbital—Rash—Dactinomycin—skin cancer	0.000243	0.00253	CcSEcCtD
Phenobarbital—Arthralgia—Docetaxel—skin cancer	0.000242	0.00252	CcSEcCtD
Phenobarbital—Myalgia—Docetaxel—skin cancer	0.000242	0.00252	CcSEcCtD
Phenobarbital—Hypersensitivity—Fluorouracil—skin cancer	0.000236	0.00247	CcSEcCtD
Phenobarbital—Confusional state—Docetaxel—skin cancer	0.000234	0.00244	CcSEcCtD
Phenobarbital—CYP2E1—head—skin cancer	0.000233	0.00535	CbGeAlD
Phenobarbital—Dizziness—Temozolomide—skin cancer	0.00023	0.0024	CcSEcCtD
Phenobarbital—Nausea—Dactinomycin—skin cancer	0.000229	0.00239	CcSEcCtD
Phenobarbital—Shock—Docetaxel—skin cancer	0.000228	0.00238	CcSEcCtD
Phenobarbital—ABCC1—lymph node—skin cancer	0.000228	0.00523	CbGeAlD
Phenobarbital—CYP3A4—female reproductive system—skin cancer	0.000224	0.00516	CbGeAlD
Phenobarbital—Vomiting—Temozolomide—skin cancer	0.000221	0.00231	CcSEcCtD
Phenobarbital—Rash—Temozolomide—skin cancer	0.00022	0.00229	CcSEcCtD
Phenobarbital—Dermatitis—Temozolomide—skin cancer	0.000219	0.00229	CcSEcCtD
Phenobarbital—Headache—Temozolomide—skin cancer	0.000218	0.00228	CcSEcCtD
Phenobarbital—Hypotension—Docetaxel—skin cancer	0.000216	0.00226	CcSEcCtD
Phenobarbital—ABCB1—epithelium—skin cancer	0.000214	0.00491	CbGeAlD
Phenobarbital—Dizziness—Fluorouracil—skin cancer	0.000212	0.00222	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000211	0.0022	CcSEcCtD
Phenobarbital—Nausea—Temozolomide—skin cancer	0.000207	0.00216	CcSEcCtD
Phenobarbital—Somnolence—Docetaxel—skin cancer	0.000206	0.00215	CcSEcCtD
Phenobarbital—Vomiting—Fluorouracil—skin cancer	0.000204	0.00213	CcSEcCtD
Phenobarbital—Rash—Fluorouracil—skin cancer	0.000202	0.00211	CcSEcCtD
Phenobarbital—Dermatitis—Fluorouracil—skin cancer	0.000202	0.00211	CcSEcCtD
Phenobarbital—Headache—Fluorouracil—skin cancer	0.000201	0.0021	CcSEcCtD
Phenobarbital—Pain—Docetaxel—skin cancer	0.000198	0.00207	CcSEcCtD
Phenobarbital—Constipation—Docetaxel—skin cancer	0.000198	0.00207	CcSEcCtD
Phenobarbital—Feeling abnormal—Docetaxel—skin cancer	0.000191	0.00199	CcSEcCtD
Phenobarbital—Nausea—Fluorouracil—skin cancer	0.000191	0.00199	CcSEcCtD
Phenobarbital—ABCB1—mammalian vulva—skin cancer	0.000185	0.00426	CbGeAlD
Phenobarbital—Body temperature increased—Docetaxel—skin cancer	0.000183	0.00191	CcSEcCtD
Phenobarbital—CYP1A1—lymph node—skin cancer	0.000179	0.00411	CbGeAlD
Phenobarbital—Hypersensitivity—Docetaxel—skin cancer	0.000171	0.00178	CcSEcCtD
Phenobarbital—ABCB1—lymphoid tissue—skin cancer	0.000165	0.00378	CbGeAlD
Phenobarbital—ABCB1—female reproductive system—skin cancer	0.000159	0.00365	CbGeAlD
Phenobarbital—Dizziness—Docetaxel—skin cancer	0.000153	0.0016	CcSEcCtD
Phenobarbital—Vomiting—Docetaxel—skin cancer	0.000147	0.00154	CcSEcCtD
Phenobarbital—Rash—Docetaxel—skin cancer	0.000146	0.00152	CcSEcCtD
Phenobarbital—Dermatitis—Docetaxel—skin cancer	0.000146	0.00152	CcSEcCtD
Phenobarbital—Headache—Docetaxel—skin cancer	0.000145	0.00151	CcSEcCtD
Phenobarbital—Nausea—Docetaxel—skin cancer	0.000138	0.00144	CcSEcCtD
Phenobarbital—ABCB1—head—skin cancer	0.000133	0.00305	CbGeAlD
Phenobarbital—ABCB1—lymph node—skin cancer	9.29e-05	0.00213	CbGeAlD
